Reporting on market developments concerning Ad Targeting Iowa Democratic Candidate for Governor Uses AI, Near-Nude Images. Industry analysts and investors are monitoring the operat...

Reporting on market developments concerning The Capitol Hill Perks That Candidates Say They Don't Deserve. Industry analysts and investors are monitoring the operational, strategic...

Alaska's unpredictable Senate contest is drawing intense scrutiny from energy markets and institutional strategists as Capitol Hill's legislative balance hangs in the balance.

Eli Lilly posted robust quarterly financial results driven by flagship injectables, though clinical nuances in its oral obesity pipeline tempered investor enthusiasm.

Surging resume fraud and sophisticated digital diploma mills are forcing employers and background screening firms to overhaul academic credential verification.

Cuauhtémoc Cárdenas, the political titan whose historic 1988 presidential campaign broke Mexico's one-party rule, has passed away at the age of 92.

U.S. mortgage rates retreated for a second straight week, offering cautious optimism to prospective homebuyers amid declining Treasury yields.

Bristol Myers Squibb is defending its clinical pipeline after a patient death in an autoimmune trial, reassuring investors over its broader immunology strategy.

Political maneuvering in Alaska's critical congressional contest highlights high-stakes battles over federal land management, resource permitting, and the national energy agenda.

As debates over the European Central Bank's next presidency gain traction, financial markets are evaluating the future path of Eurozone rate strategy and economic stability.

Eli Lilly posted significant revenue gains driven by unprecedented global demand for its blockbuster treatments Mounjaro and Zepbound, solidifying its leadership in the metabolic therapeutics market.

In an unusual operational pivot, AI-driven biotech Formation Bio has raised its own investment fund to acquire and advance clinical-stage drug candidates.